index - Epidemiology in dermatology and evaluation of therapeutics Accéder directement au contenu

DOCUMENTS

87

 

NOTICES

152

 

 

MOTS CLES

Anti-HCV Direct Acting Antivirals DAA Autoimmunity Sipuleucel-T Arthritis Addiction Etanercept Axial spondyloarthritis Spondyloarthritis Anti-Bacterial Agents Arrhythmia CSK tyrosine-protein kinase Angiotensin-converting enzyme inhibitors Glucocorticoids Epidemiology Anticancer drugs Ankylosing Biologics Adalimumab Pharmaco-Épidémiologie Beta-lactam antibiotics Cancer Biomédicaments Antibiotics Autoimmune diseases Ethics Immune checkpoint inhibitors Psoriasis Apremilast Infliximab Management Burden Placebo Stability Biologic drug Psoriatic arthritis Acute Myeloid Leukaemia AML Ankylosing spondylitis Primary adrenal insufficiency Méta-Analyse COVID-19 Biologic Cardiotoxicity Alitretinoin BTK protein Antimicrobiens Aging Azathioprine ArtThese Pregnancy Anti-TNF Endocrine toxicity Graft-versus-host disease Antibiotic misuse Vigibase® Atopic dermatitis Apre-milast ASDAS Prostate cancer Dermatology Biologic therapy Ustekinumab Pharmacoepidemiology Auto-Diagnostic Sacroiliitis Antimicrobials Albinism Treatment Antimicrobial Stewardship Accelerometer Adverse side effects Immune-related adverse events Calcium channel blockers Antibiotic resistance Biological therapy Cardio-oncology Antimicrobial resistance CTLA-4 Alcohol Immunotherapy Intensive care Biological Therapy Atrial fibrillation Biomarkers Adolescent Bacterial rhinosinusitis Amyloidosis Angiotensin receptor blockers Bacterial Access to care Auto-immune hepatitis Drug survival Abus d'antibiotiques Drug reaction Biosimilar Pharmaceuticals Quality of life Meta-Analysis Anxiété Cardiomyopathy Pharmacovigilance Anxiety

 

 

 

Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379

Adresse

Université Paris-Est Créteil Val de Marne (UPEC)

Campus Centre de Créteil
61 Avenue du Général de Gaulle
94010 Créteil Cedex

Courriel

emilie.sbidian@aphp.fr

Site Internet

 

Rattachement(s)

UFR de Santé

Direction

Émilie SBIDIAN

 

Axe(s) de recherche

 


[legende-image]65[/legende-image] Axe 1 : Comment mieux gérer les patients ayant développé des réactins graves aux médicaments, notamment en leur indiquant comment utiliser correctement les agents


[legende-image]65[/legende-image] Axe 2 : Rechercher les facteurs associés aux effets indesirables et à l'efficacité du médicament

 
 

COLLABORATIONS